Skip to content
Netherlands Society of Gene and Cell Therapy
Menu
About
History
Mission
Board Members
Committees
Honorary Members
Education
Gene Therapy Basics
Cell Therapy Basics
Antisense Oligonucleotide Therapy Basics
Approved Therapies
Research
Gene and Cell Therapy in the Netherlands
Academic research groups
National initiatives
Greiner Award
NVGCT Outstanding Achievement Award
2023 NVGCT Outstanding Achievement Award
2022 NVGCT Outstanding Achievement Award
2021 NVGCT Outstanding Achievement Award
2020 NVGCT Outstanding Achievement Award
2019 NVGCT Outstanding Achievement Award
Research News
Human Gene Therapy
Other Journals
Useful Links
Research Image Gallery
Research vacancies
Events
Webinars
Calendar
Annual Symposium
Annual Symposium 2025
Past events
Annual Symposium 2024
Annual Symposium 2023
Annual Symposium 2022
Annual Symposium 2020-2021
Spring Symposium 2019
Spring Symposium 2018
Patiënteninformatiedag Gentherapie
Get Involved
Become a Member
Become a sponsor
Contact
Patient Info (NL)
Dossier Gentherapie Stichting BWM
Patiënteninformatiedag Gentherapie
Veelgestelde vragen
Sign in
Posted on
08/03/2021
08/03/2021
by
NVGCT
Clinical development data update week 8 and 9
week89
Download
Post navigation
Previous Post
Previous
Clinical development data update week 7
Next Post
Next
bluebird bio announces that lentiviral vector BB305 is unlikely to be the cause of AML in clinical study of LentiGlobin for Sickle Cell Disease
